LCLC-97TM1Homo sapiens (Human)Cancer cell line

Also known as: Large Cell Lung Cancer-97TM1, LCLC97TM1, LCL97TM

🤖 AI SummaryBased on 7 publications

Quick Overview

Human non-small cell lung cancer cell line with large cell morphology.

Detailed Summary

LCLC-97TM1 is a human non-small cell lung cancer cell line derived from a primary tumor. It exhibits large cell morphology with features of undifferentiated carcinoma. The cell line shows high proliferation rates with a population doubling time of 26 hours. It has been used in studies related to cancer biology, drug response, and molecular profiling. The cell line is part of the Cancer Cell Line Encyclopedia (CCLE) and has been characterized for its genomic and transcriptomic features. Research on this cell line has contributed to understanding of cancer progression and therapeutic targets.

Research Applications

Cancer biologyDrug responseMolecular profiling

Key Characteristics

Large cell morphologyUndifferentiated carcinomaHigh proliferation rate
Generated on 6/16/2025

Basic Information

Database IDCVCL_1376
SpeciesHomo sapiens (Human)
Tissue SourceLung[UBERON:UBERON_0002048]

Donor Information

Age44
Age CategoryAdult
SexMale
Racecaucasian

Disease Information

DiseaseLung large cell carcinoma
LineageLung
SubtypeLarge Cell Lung Carcinoma
OncoTree CodeLCLC

DepMap Information

Source TypeDSMZ
Source IDACH-000596_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Leu35Cysfs*9 (c.102delC)Heterozygous-Unknown, Unknown
MutationSimpleKRASp.Gly12Val (c.35G>T)HeterozygousAcquiredUnknown, Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,11
D13S317
11,13
D16S539
12,13
D18S51
16
D19S433
15
D21S11
27,30
D2S1338
20
D3S1358
15
D5S818
10,12
D7S820
10,10.2,11
D8S1179
14
FGA
23
Penta D
12,15
Penta E
15
TH01
8
TPOX
8,11
vWA
19,20
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.

Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.

Nature 568:511-516(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Comparative proteome analysis across non-small cell lung cancer cell lines.

Daub H.

J. Proteomics 130:1-10(2016).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines.

Jaques G., Gropp C., Haeder M.

Differentiation 37:158-171(1988).